RBC Capital Lowers PT on Clarivate Plc (CLVT) Following Q4 2025 Results

​Clarivate Plc (NYSE:CLVT) is one of the Best Value Penny Stocks to Buy Now. On February 24, Clarivate Plc (NYSE:CLVT) released its fiscal Q4 2025 earnings. Following the release, RBC Capital lowered the firm’s price target on the stock from $5 to $3 and maintained a Sector-Perform rating.

​The company posted $617 million in revenue, reflecting 6.94% year-over-year decline and missed estimates by $12.21 million. However, the EPS of $0.20 topped estimates by $0.04. Management attributed the decline in revenue to the ongoing divestitures and disposals. Moreover, the organic subscription growth of 1% was offset by lower organic recurring and transactional revenues. Despite this, the net income for the quarter turned positive from a net loss of $191.8 million a year ago to $3.1 million.

​RBC Capital noted that the company delivered solid free cash flow growth and also guided to 10% growth for fiscal 2026. However, the firm believes that the concerns regarding the ongoing AI risks and execution in the life sciences and healthcare segment led to a lower price target.

​Clarivate Plc is a leading global provider of transformative intelligence, offering subscription-based data, analytics, and software to help organizations accelerate innovation. It serves academic, government, legal, and life sciences sectors, managing intellectual property (IP), scientific research, and pharmaceutical intelligence.​

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Follow Insider Monkey on Google News.